doi: 10.3390/nu14020355, 129
Comment: Several commenters supported the Emergency Care Access & Timeliness eCQM as an alternative to reporting the Median Time for Discharged ED Patients measure, noting that this approach recognizes the realities of REHs, such as the technological, monetary, and staffing barriers that may present challenges to eCQM adoption and use for some REHs
Strategies for managing GLP-1 side effects (nausea, fatigue)
These medications may have a direct impact on articular chondrocytes and other joint tissues, potentially improving cartilage health and reducing inflammation. As researchers drive toward this goal, early research in lupus and other conditions has offered mixed results
The incident has added to the growing scrutiny around GLP-1 receptor agonistsa drug class that includes well-known medications like Ozempic, Wegovy, and Mounjaroamid the increasing demand for obesity treatments
Researchers and the broader peptide community group these three together because each one targets a different part of how tissue heals and rebuilds
